Climb Bio (CLYM) Shares Issued (2021 - 2026)

Climb Bio has reported Shares Issued for 4 years, with the latest figure at $5000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at $5000.0 (down 100.0% YoY), and the FY2024 full-year result was $11.0 million, up 1205.47% from the prior year.
• Shares Issued for Q1 2026 stood at $5000.0, down from $41000.0 in the prior quarter.
• The five-year high for Shares Issued was $119.7 million in Q2 2024, with the low at $1000.0 in Q1 2023.
• Historically, Shares Issued has averaged $13.7 million across 3 years, with a median of $41000.0 in 2024.
• The largest YoY upside for Shares Issued was 498845.83% in 2024 against a maximum downside of 85.76% in 2024.
• Climb Bio's Shares Issued stood at $288000.0 in 2023, then slumped by 85.76% to $41000.0 in 2024, then tumbled by 87.8% to $5000.0 in 2026.
• The last three Shares Issued figures came in at $5000.0 (Q1 2026), $41000.0 (Q4 2024), and $2.3 million (Q3 2024), per Business Quant data.